Ono Pharma Foundation was developed by Ono Pharmaceutical Co. Ltd. to support Principal Investigators with discovering to new therapeutic approaches.
Ono Pharmaceutical Co., Ltd. is a leading global healthcare company committed to delivering new, innovative drugs to patients, and championing the fight against disease and pain, together with researchers, patients, their families, and healthcare providers.
DEDICATED TO MAN'S FIGHT AGAINST DISEASE AND PAIN
In 1717 in Dosho-machi, Osaka that Ichibei Fushimiya first opened his apothecary. Through its 300-year history, Ono Pharmaceutical Co. has been dedicated to developing innovative and breakthrough pharmaceutical products.
The purpose of the Ono Initiative is to support scientist Principal Investigators (“PIs”) with creative ideas in selected scientific research fields with the mission of seeking discoveries/solutions and development of high impact science. The goals of the Ono Initiative are:
Identify and help develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients.
Support academic research and the career development of promising young and established scientists.
Build strong relationships within the community in order to lead to transformative research aligned with Ono Initiative's interest.
Foundation Board and Officers
Our board is responsible for appointing members to the Scientific Advisory Board. Learn more about our Foundation Board.
Tetsuya Sugiyama, Ph.D.
Hiroshi Ochiai, Ph.D.
Shingo Hotta, Ph.D.
Scientific Advisory Board
Stuart L. Schreiber, Ph.D.
Chair of the Scientific Advisory Board